Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.

Suppr

超能文献

作者信息

Tormey D, Gelman R, Falkson G

出版信息

Am J Clin Oncol. 1983 Feb;6(1):1-18.

PMID:6340458

Abstract

摘要

相似文献

Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.

Am J Clin Oncol. 1983 Feb;6(1):1-18.

[Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].[采用两种连续化疗方案治疗晚期乳腺癌]

Medicina (B Aires). 1982;42(6 Pt 1):587-95.

Alternating versus sequential therapy in advanced breast cancer.

Medicina (B Aires). 1987;47(3):243-8.

[Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].

Rev Med Brux. 1982 Apr;3(4):209-16.

Recent progress in breast cancer management. Combined modality (adjuvant) therapy.

Arch Intern Med. 1981 Jul;141(8):1055-9.

Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.

Clin Oncol. 1980 Jun;6(2):153-7.

Multiple drug intensification after cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) induction in metastatic breast cancer: a Southeastern Cancer Study Group phase II trial.

Cancer Treat Rep. 1987 Dec;71(12):1271-3.

Combination chemotherapy of breast cancer.

Mt Sinai J Med. 1985 Jun;52(6):443-6.

Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.

Cancer Treat Rep. 1980 Aug-Sep;64(8-9):981-4.

Chemotherapy for breast cancer.乳腺癌的化疗

J Reprod Med. 1979 Jul;23(1):3-11.

引用本文的文献

Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.糖皮质激素对非血液系统恶性肿瘤临床疗效的系统评价

BMC Cancer. 2008 Mar 28;8:84. doi: 10.1186/1471-2407-8-84.

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.白细胞最低点作为辅助性CMF方案治疗的淋巴结阳性乳腺癌化疗疗效的标志物。

Br J Cancer. 1999 Aug;80(11):1763-6. doi: 10.1038/sj.bjc.6690594.

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.血液学毒性：II期和III期乳腺癌辅助化疗疗效的一个标志物。

Br J Cancer. 1997;75(2):301-5. doi: 10.1038/bjc.1997.49.

Postmenopausal breast cancer. Drug therapy in the 1990s.绝经后乳腺癌。20世纪90年代的药物治疗。

Drugs Aging. 1993 Mar-Apr;3(2):106-21. doi: 10.2165/00002512-199303020-00002.

CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).CMF方案与交替使用CMF/EV方案在可手术乳腺癌辅助治疗中的比较。一项单中心随机临床试验（那不勒斯GUN-3研究）。

Br J Cancer. 1995 Jun;71(6):1283-7. doi: 10.1038/bjc.1995.248.

Chemotherapy of breast cancer.乳腺癌的化疗

Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.

Long-term tamoxifen adjuvant therapy in node-positive breast cancer: a metabolic and pilot clinical study.淋巴结阳性乳腺癌的长期他莫昔芬辅助治疗：一项代谢及初步临床研究。

Breast Cancer Res Treat. 1984;4(4):297-302. doi: 10.1007/BF01806042.

Current status of chemotherapy of breast cancer.乳腺癌化疗的现状

Drugs. 1984 Aug;28(2):93-8. doi: 10.2165/00003495-198428020-00001.

A randomized trial of two regimens of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone in advanced breast cancer.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶和泼尼松两种方案治疗晚期乳腺癌的随机试验。

Cancer Chemother Pharmacol. 1986;17(1):87-90. doi: 10.1007/BF00299873.

Short term high density systemic therapy for metastatic breast cancer.转移性乳腺癌的短期高密度全身治疗

Breast Cancer Res Treat. 1985;5(2):177-88. doi: 10.1007/BF01805992.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验